SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Shares of several companies with operations involving convalescent plasma are trading higher after the FDA issued emergency use authorization for convalescent plasma as a potential COVID–19 treatment.

Benzinga · 08/24/2020 11:34